On March 12, 2023, Changa Institute in Oregon celebrated a milestone by graduating its first Psilocybin Facilitator cohort. Two graduates, David Naftalin and Jeanette Small, became among the first licensed psilocybin facilitators in Oregon and have since launched successful businesses. Changa Institute offers high-quality education, taught by leading experts in psychedelic research, with over 120 hours of live classes and diverse guest speakers. Explore our Psilocybin Facilitator Program today for a career in psychedelic therapy.

On June 4th, 2024, federal health advisers rejected a proposal to use MDMA for PTSD treatment, citing concerns about safety and efficacy. Now, the FDA must make the final decision, a crucial moment for patients, researchers, and advocates. Comprehensive research from the Changa Institute supports the benefits of MDMA-assisted therapy. Studies, including a Phase 3 trial by MAPS, show significant potential in reducing PTSD symptoms. At the Changa Institute, we emphasize the importance of professionally trained facilitators for safe and effective therapy. Discover the benefits of psychedelic therapy and stay informed on this pivotal issue.